Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.

<h4>Background</h4>Ovarian cancer is the second most prevalent gynecologic cancer in women. However, it is by far the most lethal. This is generally attributed to the absence of easily detectable markers specific to ovarian cancers that can be used for early diagnosis and specific therap...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jan Rohozinski, Matthew L Anderson, Russell E Broaddus, Creighton L Edwards, Colin E Bishop
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2009
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ff51371b9fe64c29983ea1f80755080a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ff51371b9fe64c29983ea1f80755080a
record_format dspace
spelling oai:doaj.org-article:ff51371b9fe64c29983ea1f80755080a2021-11-25T06:16:25ZSpermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.1932-620310.1371/journal.pone.0005064https://doaj.org/article/ff51371b9fe64c29983ea1f80755080a2009-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19333399/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Ovarian cancer is the second most prevalent gynecologic cancer in women. However, it is by far the most lethal. This is generally attributed to the absence of easily detectable markers specific to ovarian cancers that can be used for early diagnosis and specific therapeutic targets.<h4>Methodology/principal findings</h4>Using end point PCR we have found that a family of retrogenes, previously thought to be expressed only in the male testis during spermatogenesis in man, are also expressed in normal ovarian tissue and a large percentage of ovarian cancers. In man there are at least eleven such autosomal retrogenes, which are intronless copies of genes on the X chromosome, essential for normal spermatogenesis and expressed specifically in the human testis. We tested for the expression of five of the known retrogenes, UTP14C, PGK2, RPL10L, RPL39L and UBL4B in normal human ovary and ovarian cancers.<h4>Conclusions/significance</h4>We propose that the activation of the testis specific retrogenes in the ovary and ovarian cancers is of biological significance in humans. Because these retrogenes are specifically expressed in the ovary and ovarian cancers in the female they may prove useful in developing new diagnostic and/or therapeutic targets for ovarian cancer.Jan RohozinskiMatthew L AndersonRussell E BroaddusCreighton L EdwardsColin E BishopPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 4, Iss 3, p e5064 (2009)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jan Rohozinski
Matthew L Anderson
Russell E Broaddus
Creighton L Edwards
Colin E Bishop
Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.
description <h4>Background</h4>Ovarian cancer is the second most prevalent gynecologic cancer in women. However, it is by far the most lethal. This is generally attributed to the absence of easily detectable markers specific to ovarian cancers that can be used for early diagnosis and specific therapeutic targets.<h4>Methodology/principal findings</h4>Using end point PCR we have found that a family of retrogenes, previously thought to be expressed only in the male testis during spermatogenesis in man, are also expressed in normal ovarian tissue and a large percentage of ovarian cancers. In man there are at least eleven such autosomal retrogenes, which are intronless copies of genes on the X chromosome, essential for normal spermatogenesis and expressed specifically in the human testis. We tested for the expression of five of the known retrogenes, UTP14C, PGK2, RPL10L, RPL39L and UBL4B in normal human ovary and ovarian cancers.<h4>Conclusions/significance</h4>We propose that the activation of the testis specific retrogenes in the ovary and ovarian cancers is of biological significance in humans. Because these retrogenes are specifically expressed in the ovary and ovarian cancers in the female they may prove useful in developing new diagnostic and/or therapeutic targets for ovarian cancer.
format article
author Jan Rohozinski
Matthew L Anderson
Russell E Broaddus
Creighton L Edwards
Colin E Bishop
author_facet Jan Rohozinski
Matthew L Anderson
Russell E Broaddus
Creighton L Edwards
Colin E Bishop
author_sort Jan Rohozinski
title Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.
title_short Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.
title_full Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.
title_fullStr Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.
title_full_unstemmed Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.
title_sort spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.
publisher Public Library of Science (PLoS)
publishDate 2009
url https://doaj.org/article/ff51371b9fe64c29983ea1f80755080a
work_keys_str_mv AT janrohozinski spermatogenesisassociatedretrogenesareexpressedinthehumanovaryandovariancancers
AT matthewlanderson spermatogenesisassociatedretrogenesareexpressedinthehumanovaryandovariancancers
AT russellebroaddus spermatogenesisassociatedretrogenesareexpressedinthehumanovaryandovariancancers
AT creightonledwards spermatogenesisassociatedretrogenesareexpressedinthehumanovaryandovariancancers
AT colinebishop spermatogenesisassociatedretrogenesareexpressedinthehumanovaryandovariancancers
_version_ 1718414022058967040